MEDDESKTOP

NPI Registry, International Classification of Diseases,ICD,HCPCS, , CPT, National Drug Codes,NDC, SNOMED CT, MEDCIN, Medical news, Health news, Healthcare news, General welfare, and healthy living will bring forth a healthy society. This site is not intended to provide medical advice, diagnosis or treatment. Disclosure; This site shows ads compensated for them.

Friday, April 30, 2010

McNeil Consumer Healthcare Recalls over-the-counter (OTC) Children’s and Infants’ liquid products including Tylenol, Motrin, Zyrtec, and Benadryl products

›
[Posted 04/30/2010] McNeil Consumer Healthcare and FDA notified healthcare professionals of a voluntary recall of certain over-the-counter (...

Cardiac Science Automated External Defibrillators : Class I Recall Adds - Powerheart, Cardiovive, NK, Responder models

›
[UPDATED 04/27/2010] This update alerts users that Nihon Kohden (NK) and GE Responder models are also affected although they were not identi...

Serious Liver Disorder with Videx (didanosine) or Videx EC.

›
FDA is notifying healthcare professionals about cases of a rare but serious complication, non-cirrhotic portal hypertension, in patients tak...

Meridia (sibutramine) increases their risk of heart attack and stroke in patients with a history of cardiovascular disease

›
FDA is alerting healthcare professionals that Meridia (sibutramine) is contraindicated in patients with a history of cardiovascular disease...

Association of INVIRASE® (saquinavir mesylate) with significant dose-dependent prolongations of QT and PR intervals in healthy volunteers

›
Invirase (saquinavir mesylate) Hoffmann-La Roche Limited, in consultation with Health Canada, would like to inform healthcare professionals ...

FDA has added a Boxed Warning to the label for propylthiouracil, to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.

›
Propylthiouracil Audience : Endocrine healthcare professionals, Pharmacists, Pediatricians [Updated 04/21/2010] FDA has added a Boxed Warni...

Promethazine is not to be used in children under the age of two years due to the potentially fatal risk of respiratory depression (slowed breathing).

›
Promethazine is not to be used in children under the age of two years due to the potentially fatal risk of respiratory depression (slowed br...
‹
›
Home
View web version

Contributors

  • OncoWikia
  • ravenII
  • sol@rion
Powered by Blogger.